Loading…
← CockpitCompetitor Analysis › BOW Bowhead Specialty Holdings Inc.Open in the cockpit ↗

Bowhead Specialty Holdings Inc.BOWCompetitor analysis, valuation and peers

United States · USD·Financials›Multi-Line Insurance

US specialty insurer underwriting excess & surplus lines property, casualty and professional liability risks.

Momentum strong 75
Mkt cap
$1.13B
US dollars, full cap
Free float
93%
of shares outstanding
$/day
$7.47M
20-day average traded
P/B
2.50×
price to book
ROE
13.6%
delivered
Implied ROE
11.9%
what the price asks
Next earnings
104 days
2 Mar 2027
Close · USD$34.31
1D+0.4%
1W+0.4%
1M+0.8%
3M+2.5%
6M+20.1%
YTD+20.2%
1Y+23.9%
ATR %0.7%
Beta0.03
52w lowhigh2.2% off high

What Bowhead Specialty does

US specialty insurer underwriting excess & surplus lines property, casualty and professional liability risks.

Sells almost entirely through wholesale brokers, who place hard-to-insure commercial risks that standard insurers decline; it passes part of each risk to reinsurers and earns underwriting profit plus income on the premiums it holds before claims are paid. A young company that came to market in 2024.

Products and services

  • Casualty (E&S)
  • Professional liability
  • Healthcare liability

Customers

  • Commercial businesses with complex risk

Where it sits in the supply chain

  • Financials
  • Insurance
  • Specialty/E&S commercial insurance

What could go right

  • Hard E&S casualty pricing cycle
  • New program launches

What could go wrong

  • Casualty reserve adequacy risk
  • Competitive softening in E&S market

Moat: narrow (process know-how, distribution). Experienced underwriting team targeting complex E&S casualty niches underserved by standard carriers.

Headquarters: New York, New York, United States · Founded: 2020 · Employees: 296

Named competitors

Bowhead Specialty at a glance

Size Bowhead Specialty (BOW) is a United States Financials company (Multi-Line Insurance) with a market value of $1.13B, the 2154th largest of 3,085 United States companies the cockpit tracks. Shares closed at $34.31 on 18 Nov 2026.

Performance Over six months the shares gained 20.1%, against -1.6% for the median peer and -2.2% for the United States market (cap-weighted) — 4th highest of 21 in its peer set.

Growth Revenue grew 23.6% over the last twelve months (peer median +9.6%); the operating margin is 15.1% (peer median 9.1%).

Valuation It trades at 2.50× book value against a peer median of 0.92× (6th most expensive of 21).

Price implies The share price implies a return on equity of about 11.9%; Bowhead Specialty delivers 13.6%, so the price asks less than the business earns today.

Short interest Short interest is 4.6% of the free float (30 Oct 2026).

Next results Next results expected around 2 Mar 2027 (exchange calendar; dates can move).

Relative performance

10012021 May 202621 Aug 202618 Nov 2026BOW 121Peer median 97
Six months, rebased to 100: Bowhead Specialty against the median of its 20 peers (local-currency closes).

Bowhead Specialty financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$640M$550M$426M$283M$188M
Revenue growth—+29%+50%+51%—
Net income$59.9M$53.8M$38.2M$25.0M$11.3M
Free cash flow$403M$324M$291M$232M$178M
Capital expenditure$5.42M$5.57M$3.11M$3.82M$3.97M
Total debt$147M$149M$4.30M$0$0

Quarterly statements and history in the cockpit →

Bowhead Specialty competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-20%0%+20%+40%-10%0%+10%2851CSNWUWLDATRUPRELIGAREDGICA0036906060031210NHFPLGOGODIGITAIFU0662NIACLSKWDGNWBOW6-month return →1-month return →
Up and to the right = strong over both horizons. Bowhead Specialty is the large dot.

Fundamentals: return on equity against price-to-book

0%10%20%10×20×30×2851CSNWUWLDASFCTRUPRELIGAREDGICA0036906060031210NHFPLGOGODIGITAIFU0662VAHNNIACLSKWDGNWBOWReturn on equity →Price / book →
A bank or insurer earning more on its equity usually trades at a higher multiple of book; points far above the trend are priced for more. Bowhead Specialty is the large dot.

Capital: ROE delivered against the ROE the price implies

-100%-50%0%-100%-50%0%2851CSNWUWLDASFCTRUPGODIGITAIFUBOWROE delivered →ROE the price implies →
Above the diagonal = the price asks for a higher return on equity than the business earns today. Bowhead Specialty is the large dot.

Bowhead Specialty competitors and peer comparison

Head to head with its named competitors (BOW vs SKWD vs KNSL vs RLI)
CompanyMarket cap6M returnRevenue growthROEPrice / bookImplied ROE
Bowhead Specialty BOW$1.13B+20%+24%14%2.50×11.9%
Skyward Specialty Insurance SKWD$2.82B+34%+35%17%2.21×11.0%
Kinsale Capital KNSL$8.97B+28%+8%28%4.88×32.7%
RLI RLI$6.55B+36%+6%22%3.86×16.8%
Palomar PLMR$4.14B+36%+59%23%4.20×18.0%

How Bowhead Specialty compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Bowhead Specialty against its 20 peers (data as of 18 Nov 2026)
MeasureBOWPeer medianRank in peer set
1-month return+0.8%+1.4%10th lowest of 21
6-month return+20.1%-1.6%4th highest of 21
Return on equity13.6%7.5%7th highest of 21
Price / book2.50×0.92×6th most expensive of 21
Trailing P/E19.2×14.4×7th most expensive of 19
ROE the price implies11.9%6.7%8th most demanding of 21
ROE delivered13.6%8.1%7th highest of 20

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthROEPrice / bookImplied ROEDelivered ROE
Bowhead Specialty BOWUnited States$1.13B+20%+24%14%2.50×11.9%13.6%
Central Reinsurance 2851.TWTaiwan$1.06B+38%+3%35%1.31×4.9%35.2%
Chesnara CSN.LUnited Kingdom$1.05B+6%+192%0%2.12×15.9%0.3%
Wuestenrot & Wuerttembergische WUW.DEGermany$1.39B-8%+4%3%0.25×3.8%2.7%
Linea Directa Aseguradora LDA.MCSpain$1.50B+6%+10%23%3.17×12.3%23.3%
Sagicor Financial SFC.TOCanada$809M+1%-11%1%0.82×4.9%1.5%
Trupanion TRUPUnited States$1.59B+68%+11%7%3.98×36.4%6.9%
Religare Enterprises RELIGARE.NSIndia$804M-3%+18%3%2.53×22.8%n/a
Donegal DGICAUnited States$758M+9%-3%11%1.05×6.8%10.7%
Korean Reinsurance 003690.KSSouth Korea$1.71B+5%+10%14%0.75×4.9%13.7%
Zhongan Online P&C Insurance 6060.HKHong Kong$1.87B-19%+16%8%0.47×7.6%8.2%
Seoul Guarantee Insurance 031210.KSSouth Korea$2.11B-13%+19%6%0.57×4.5%5.6%
NIB NHF.AXAustralia$2.24B0%+5%17%2.93×13.3%16.6%
Pelagos Insurance Capital PLGOUnited States$2.28B+19%+4%15%1.02×6.6%14.6%
Go Digit General Insurance GODIGIT.NSIndia$2.38B-23%+12%8%2.73×22.4%8.1%
AIFU AIFUUnited States$517M-81%-47%-113%0.32×5.1%-113.4%
Asia Financial 0662.HKHong Kong$500M-10%+6%10%0.29×3.7%10.2%
Vaudoise Assurances VAHN.SWSwitzerland$2.62B-3%+14%6%0.79×1.9%5.9%
New India Assurance NIACL.NSIndia$2.64B-9%+9%-1%0.59×13.5%-1.3%
Skyward Specialty Insurance SKWDUnited States$2.82B+34%+35%17%2.21×11.0%17.1%
Genworth Financial GNWUnited States$2.88B-15%-3%0%0.34×5.2%0.4%

Questions

Who are Bowhead Specialty's main competitors?
Named competitors: Skyward Specialty Insurance (SKWD), Kinsale Capital Group (KNSL), RLI Corp (RLI), Palomar Holdings (PLMR). The cockpit's measured peer set (industry) also includes Central Reinsurance (2851.TW), Chesnara (CSN.L), Wuestenrot & Wuerttembergische (WUW.DE), Linea Directa Aseguradora (LDA.MC), Sagicor Financial (SFC.TO), Trupanion (TRUP).
Is Bowhead Specialty expensive compared with its peers?
On price / book it trades at 2.50× against a peer median of 0.92×, 6th most expensive of 21 in its peer set. The share price implies a return on equity of about 11.9%; Bowhead Specialty delivers 13.6%, so the price asks less than the business earns today.
How has Bowhead Specialty stock performed?
Over six months to 18 Nov 2026 the shares returned +20.1% against -1.6% for the median peer; over one year +23.9%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.